Unexpected Need of the Epidermal Growth Factor Receptor Tyrosine Kinase Activity for Signaling by Intracellular Pattern Recognition Receptors of Nucleic Acids

被引:0
|
作者
Sen, Ganes C. [1 ,2 ]
Kessler, Patricia M. [1 ]
机构
[1] Cleveland Clin, Lerner Res Inst, Dept Inflammat & Immun, Cleveland, OH USA
[2] Cleveland Clin, Lerner Res Inst, Dept Inflammat & Immun, Cleveland, OH 44195 USA
基金
美国国家卫生研究院;
关键词
EGFR; tyrosine phosphorylation; cross-talk between growth factor and TLRs; TOLL-LIKE RECEPTOR-3; DOUBLE-STRANDED-RNA; EGFR; PHOSPHORYLATION; REQUIRES; PATHWAY; ADAPTER; TRIF;
D O I
10.1089/jir.2023.0016
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Many pattern recognition receptors in mammalian cells initiate signaling processes that culminate in mounting an innate protective response mediated by induced synthesis of a large number of proteins including type I interferons and other cytokines. Many of these receptors are not located on the plasma membrane but on the membranes of intracellular organelles such as endosomes, mitochondria, and the endoplasmic reticulum; they primarily recognize microbial or cellular nucleic acids. In the course of biochemical analyses of the signaling pathways triggered by these receptors, we discovered that they require tyrosine phosphorylation by the protein kinase activity of the epidermal growth factor receptor (EGFR), which is located not only on the plasma membrane but also on the intracellular membranes. Here, we discuss how specific members of this family of receptors, such as TLR3, TLR9, or STING, interact with EGFR and other protein tyrosine kinases and what are the functional consequences of their post-translational modifications. The article highlights an unexpected functional link between a growth factor receptor and cellular innate immune response.
引用
收藏
页码:189 / 193
页数:5
相关论文
共 50 条
  • [41] Tyrosine dephosphorylation enhances the therapeutic target activity of epidermal growth factor receptor (EGFR) by disrupting its interaction with estrogen receptor (ER)
    Ma, Shao
    Yin, Ning
    Qi, Xiaomei
    Pfister, Sandra L.
    Zhang, Mei-Jie
    Ma, Rong
    Chen, Guan
    ONCOTARGET, 2015, 6 (15) : 13320 - 13333
  • [42] Antitumor activity of histone deacetylase inhibitor chidamide alone or in combination with epidermal growth factor receptor tyrosine kinase inhibitor icotinib in NSCLC
    Zhang, Ningning
    Liang, Caixia
    Song, Wenya
    Tao, Dan
    Yao, Jiarui
    Wang, Shuai
    Ma, Li
    Shi, Yuankai
    Han, Xiaohong
    JOURNAL OF CANCER, 2019, 10 (05): : 1275 - 1287
  • [43] Overcoming Molecular Mechanisms of Resistance to First-Generation Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors
    Bar, Jair
    Onn, Amir
    CLINICAL LUNG CANCER, 2012, 13 (04) : 267 - 279
  • [44] Anti-epidermal growth factor receptor tyrosine kinase activities of traditional Chinese medicine for cancer treatment
    Wang, Zenghui
    Lin, Sensen
    Wang, Dongmei
    Huang, Linfang
    EUROPEAN JOURNAL OF INTEGRATIVE MEDICINE, 2014, 6 (05) : 565 - 570
  • [45] Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors in breast cancer: Current status and future development
    Normanno, N
    De Luca, A
    Maiello, MR
    Mancino, M
    D'Antonio, A
    Macaluso, M
    Caponigro, F
    Giordano, A
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2005, 10 : 2611 - 2617
  • [46] Resistance to epidermal growth factor receptor tyrosine kinase inhibitors, T790M, and clinical trials
    O'Kane, G. M.
    Barnes, T. A.
    Leighl, N. B.
    CURRENT ONCOLOGY, 2018, 25 : S28 - S37
  • [47] Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Advanced Non-Small Cell Lung Cancer
    Ogunleye, Foluso
    Ibrahim, Mohammed
    Stender, Michael
    Kalemkerian, Gregory
    Jaiyesimi, Ishmael
    AMERICAN JOURNAL OF HEMATOLOGY-ONCOLOGY, 2015, 11 (01) : 16 - 25
  • [48] MODERN VECTOR IN TREATMENT OF PATIENTS WITH LUNG CANCER: TYROSINE KINASE INHIBITORS IN EPIDERMAL GROWTH FACTOR RECEPTOR MUTATIONS
    Smorodska, O. M.
    Moskalenko, Yu, V
    Vynnychenko, I. O.
    Vynnychenko, O., I
    Kostuchenko, V. V.
    MEDICNI PERSPEKTIVI, 2021, 26 (02): : 4 - 11
  • [49] Knockdown of GnT-Va expression inhibits ligand-induced downregulation of the epidermal growth factor receptor and intracellular signaling by inhibiting receptor endocytosis
    Guo, Hua-Bei
    Johnson, Heather
    Randolph, Matthew
    Lee, Intaek
    Pierce, Michael
    GLYCOBIOLOGY, 2009, 19 (05) : 547 - 559
  • [50] New Strategies in Overcoming Acquired Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Lung Cancer
    Oxnard, Geoffrey R.
    Arcila, Maria E.
    Chmielecki, Juliann
    Ladanyi, Marc
    Miller, Vincent A.
    Pao, William
    CLINICAL CANCER RESEARCH, 2011, 17 (17) : 5530 - 5537